US Patent 9938530 RNA interference in skin indications
Patent 9938530 was granted and assigned to Rxi Pharmaceuticals Corporation on April, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+182 characters)
Article
Patent abstract
The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications.
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09938530 RNA interference in skin indications US Patent 9938530 RNA interference in skin indications
Infobox
Patent Number
0993853000
Patent Number
993853000
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
099385300
Date of Patent
April 10, 2018
0Patent Application Number
150417380
Date Filed
February 11, 2016
0Patent Primary Examiner
Edits on 5 Oct, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
099385300
Date of Patent
April 10, 2018
0Patent Application Number
150417380
Date Filed
February 11, 2016
0Patent Primary Examiner
Edits on 19 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09938530 RNA interference in skin indications
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09938530
Date of patent
April 10, 2018
Patent application number
15041738
Date Filed
February 11, 2016
Patent primary examiner
Find more entities like US Patent 9938530 RNA interference in skin indications
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.